SO
59
-5
MHK
37
-5
LMT
29
-21
VLO
45
-3
HSIC
54
-2
MSFT
53
3
PNC
61
4
K
60
7
BXP
46
2
CCL
58
-2
TSCO
50
5
ABBV
64
-4
GPC
48
-3
EMC
39
-3
URBN
51
-3
AAL
26
2
MTB
52
2
WU
48
-2
ADSK
52
3
BLK
64
-2
SO
59
-5
MHK
37
-5
LMT
29
-21
VLO
45
-3
HSIC
54
-2
MSFT
53
3
PNC
61
4
K
60
7
BXP
46
2
CCL
58
-2
TSCO
50
5
ABBV
64
-4
GPC
48
-3
EMC
39
-3
URBN
51
-3
AAL
26
2
MTB
52
2
WU
48
-2
ADSK
52
3
BLK
64
-2
Financhill
Back

Adtran Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
38

ADTN
Adtran Holdings

Last Price:
$9.17
Seasonality Move:
9.53%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$74.08
Seasonality Move:
14.66%
Sell
38
Adtran Holdings (ADTN) is a Sell

Is Adtran Holdings a Buy, Sell or Hold?

  • The current Adtran Holdings [ADTN] share price is $9.21. The Score for ADTN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ADTN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADTN Stock Price Chart

What is Adtran Holdings's stock price today?

  • The Adtran Holdings share price today is $9.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADTN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $74.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

ADTN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 42.49 Sell
Chaikin Money Flow: 975251 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.08 - 11.2) Sell
Bollinger Bands (100): (7.59 - 10.53) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.7 Sell
Relative Strength Index (14 RSI): 27.9 Sell
Chaikin Money Flow: -367389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.59 - 111.17) Sell
Bollinger Bands (100): (103.29 - 127.87) Sell

ADTN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.03 Buy
20-day SMA: 9.79 Sell
50-day SMA: 10.24 Sell
200-day SMA: 7.31 Buy
8-day EMA: 9.17 Buy
20-day EMA: 9.61 Sell
50-day EMA: 9.74 Sell
200-day EMA: 8.17 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.22 Sell
20-day SMA: 97.87 Sell
50-day SMA: 108.64 Sell
200-day SMA: 125.16 Sell
8-day EMA: 84.58 Sell
20-day EMA: 94.74 Sell
50-day EMA: 105.16 Sell
200-day EMA: 118.38 Sell

Adtran Holdings Earnings Growth & ADTN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.01 per share, an increase this year of $0.55 per share, and an increase next year of $0.26 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Adtran Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):